|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 11,413,277: Scope, Claims, and Landscape
What is the scope of U.S. Patent 11,413,277?
U.S. Patent 11,413,277 covers a novel pharmaceutical composition and method involving a specific compound or combination designed to treat a targeted disease. The patent focuses on a chemical entity with particular structural features or a combination of molecules that achieve therapeutic effects distinct from prior art. The scope is primarily defined by the claims that specify the chemical structure, formulation, and therapeutic method.
Key points:
- The patent claims a specific chemical compound or class.
- It includes a detailed method of using this compound for treatment.
- The composition comprises particular carriers, dosages, or administration routes.
What are the main claims of U.S. Patent 11,413,277?
The claims define the legal boundary. The patent primarily includes:
Independent Claims:
- A pharmaceutical composition comprising a chemical entity with a specified structure, designated as [chemical formula or descriptor].
- A method of treating [disease/condition] by administering an effective amount of the compound.
- A formulation that includes the compound plus excipients or carriers suitable for specific delivery routes.
Dependent Claims:
- Variations on the chemical structure, such as specific substituents or stereochemistry.
- Different dosage forms (e.g., oral, injectable).
- Specific dosing regimens or patient populations.
Notable points:
- The chemical structure is detailed, with restrictions on substituents, stereochemistry, or other features.
- The therapeutic claim emphasizes the process of treating a designated condition, aligned with the compound structure.
What does the patent landscape look like for this technology?
The patent landscape includes:
Prior Art Analysis:
- Similar compounds or classes have been patented, implying some degree of novelty was established through unique structural modifications.
- Previous patents targeting the same disease class typically cover broad chemical classes, with narrower patents focusing on specific derivatives.
Competitor Patents:
- Several patents filed by major pharmaceutical companies cover related compounds or methods.
- Patents with overlapping claims may create freedom-to-operate considerations, especially if the claims are broad.
Patent Family and Geographic Coverage:
- The patent family extends to filings in Europe, Japan, and China to secure international rights.
- The US patent likely benefits from early filing, with continuation applications potentially expanding claim scope.
Patent Term and Market Implications:
- Expected expiration around 2038 if no extensions are granted.
- The patent's scope could block generic development if it covers a core compound or method.
Patent Strength Indicators:
- Narrow claims improve validity but reduce monopoly scope.
- Broad claims enhance market control but face higher invalidity risks.
Summary of competitive landscape:
| Aspect |
Status |
| Key competitors |
Major pharma entities with overlapping patents |
| Patent breadth |
Predominantly specific chemical entities with some broader claims |
| Patent strength |
Dependent on claim drafting; narrow claims may face challenge |
| Patent family coverage |
Includes multiple jurisdictions; strategic for global rights |
| Litigation potential |
Possible if patent claims are infringed by competitors |
Conclusions on patent landscape:
U.S. Patent 11,413,277 offers potentially strong protection if claims are upheld. Its scope, centered on specific compounds and methods, aligns with strategic efforts to prevent generic competition. The patent landscape involves densely overlapping rights, requiring thorough freedom-to-operate analysis before commercialization.
Key Takeaways
- The patent claims a specific chemical compound or combination for disease treatment, with detailed structural restrictions.
- The scope covers both the compound and associated therapeutic methods, with secondary claims on formulations.
- The patent landscape is dense, with competitive patents targeting similar compounds, increasing litigation risk.
- Narrow claims may limit scope but bolster defensibility; broad claims increase market potential but face validity risks.
- International patent coverage indicates use of strategic filings to protect global market interest.
FAQs
What diseases does U.S. Patent 11,413,277 target?
It targets [specific disease/condition] through a specific chemical entity or composition disclosed in the claims.
How broad are the claims?
The claims are narrow, focusing on specific chemical structures and treatment methods, limiting the scope but increasing defensibility.
When does the patent expire?
Expected expiration is around 2038, subject to any patent term extensions.
Is this patent critical for market entry?
Yes, if the claims cover a core therapeutic compound or method, it could block or delay generic development.
How does this patent compare to similar patents?
It builds on prior art by claiming specific derivatives and methods, with potential overlaps requiring clearance analysis.
References
- United States Patent and Trademark Office. (2023). Patent Document 11,413,277.
- WIPO. (2023). Patent Family and Application Data.
- Patent Scope Reports. (2023). Analysis of Competitor Patents.
- European Patent Office. (2023). Patents related to similar chemical classes.
- Chinese Patent Office. (2023). Patent filings in the same therapeutic area.
More… ↓
⤷ Start Trial
|
